Jim Simons Astria Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 179,161 shares of ATXS stock, worth $886,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares

179,161

Holding current value

$886,846

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$5.34 - $9.1 $956,719 - $1.63 Million	179,161 New	179,161 $956,000
Q3 2024 Nov 13, 2024	BUY	$8.97 - $12.65 $139,932 - $197,340	15,600 Added 69.45%	38,061 $419,000
Q2 2024 Aug 09, 2024	SELL	$8.83 - $13.51 $167,231 - $255,865	-18,939 Reduced 45.75%	22,461 $204,000
Q1 2024 May 13, 2024	BUY	$6.99 - $16.69 $190,128 - $453,968	27,200 Added 191.55%	41,400 $583,000
Q4 2023 Feb 13, 2024	BUY	$4.42 - $8.06 $18,122 - $33,046	4,100 Added 40.59%	14,200 $109,000
Q3 2023 Nov 14, 2023	SELL	$6.89 - $9.86 $557,821 - $798,275	-80,961 Reduced 88.91%	10,100 $75,000
Q2 2023 Aug 11, 2023	BUY	$8.33 - $13.72 $356,199 - $586,680	42,761 Added 88.53%	91,061 $759,000
Q1 2023 May 12, 2023	SELL	$11.2 - $15.79 $380,363 - $536,244	-33,961 Reduced 41.28%	48,300 $642,000
Q4 2022 Feb 13, 2023	BUY	$7.44 - $14.89 $181,536 - $363,316	24,400 Added 42.17%	82,261 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$2.97 - $10.34 $131,158 - $456,624	44,161 Added 322.34%	57,861 $523,000
Q2 2022 Aug 12, 2022	BUY	$2.46 - $6.96 $33,702 - $95,352	13,700 New	13,700 $41,000
Q1 2022 May 13, 2022	SELL	$3.92 - $7.1 $134,695 - $243,963	-34,361 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$5.08 - $8.62 $380,959 - $646,431	-74,992 Reduced 68.58%	34,361 $185,000
Q3 2021 Nov 12, 2021	BUY	$7.32 - $12.9 $800,463 - $1.41 Million	109,353 New	109,353 $967,000

Others Institutions Holding ATXS

# of Institutions

119

Shares Held

51.1M

Call Options Held

5.3K

Put Options Held

6.1K

View Full List

About Astria Therapeutics, Inc.

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $75.1M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

More about ATXS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account